头颈癌的治疗——有时，少即是多。 - Suppr

Suppr

超能文献

Treatment of Head and Neck Cancer-Sometimes, Less Is More.

作者信息

Galloway Thomas J, Ridge John A

机构信息

Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

出版信息

JAMA Otolaryngol Head Neck Surg. 2019 Dec 1;145(12):1167-1169. doi: 10.1001/jamaoto.2019.3078.

DOI:10.1001/jamaoto.2019.3078

PMID:31621802

Abstract

摘要

相似文献

Treatment of Head and Neck Cancer-Sometimes, Less Is More.

JAMA Otolaryngol Head Neck Surg. 2019 Dec 1;145(12):1167-1169. doi: 10.1001/jamaoto.2019.3078.

Aspiration pneumonia after concurrent chemoradiotherapy for head and neck cancer.

Cancer. 2015 Apr 15;121(8):1303-11. doi: 10.1002/cncr.29207. Epub 2014 Dec 23.

Survival of patients with head and neck cancer treated with definitive radiotherapy and concurrent cisplatin or concurrent cetuximab: A Surveillance, Epidemiology, and End Results-Medicare analysis.

Cancer. 2018 Dec 1;124(23):4486-4494. doi: 10.1002/cncr.31708. Epub 2018 Oct 17.

Improved overall survival and mortality in head and neck cancer with adjuvant concurrent chemoradiotherapy in national databases.

Head Neck. 2016 Feb;38(2):208-15. doi: 10.1002/hed.23869. Epub 2015 May 25.

Easing acceleration of head and neck chemoradiotherapy.

Lancet Oncol. 2012 Feb;13(2):113-5. doi: 10.1016/S1470-2045(11)70382-5. Epub 2012 Jan 18.

Concurrent chemoradiotherapy in older adults with squamous cell head & neck cancer: Evidence and management.

J Geriatr Oncol. 2016 May;7(3):145-53. doi: 10.1016/j.jgo.2016.01.010. Epub 2016 Feb 28.

Definitive radiation with concurrent cetuximab vs. radiation with or without concurrent cytotoxic chemotherapy in older patients with squamous cell carcinoma of the head and neck: Analysis of the SEER-medicare linked database.

Oral Oncol. 2018 Nov;86:132-140. doi: 10.1016/j.oraloncology.2018.09.023. Epub 2018 Sep 21.

Primary surgery for advanced-stage laryngeal cancer: A stage and subsite-specific survival analysis.

Head Neck. 2016 Sep;38(9):1380-6. doi: 10.1002/hed.24443. Epub 2016 Mar 25.

Survival After Definitive Chemoradiotherapy With Concurrent Cisplatin or Carboplatin for Head and Neck Cancer.

J Natl Compr Canc Netw. 2019 Sep 1;17(9):1065-1073. doi: 10.6004/jnccn.2019.7297.

Intra-arterial chemoradiotherapy for head and neck cancer.

Jpn J Clin Oncol. 2016 Jan;46(1):4-12. doi: 10.1093/jjco/hyv151. Epub 2015 Oct 20.

引用本文的文献

Microscopic Extranodal Extension in HPV-Negative Head and Neck Cancer and the Role of Adjuvant Chemoradiation.

Otolaryngol Head Neck Surg. 2021 Oct;165(4):536-549. doi: 10.1177/0194599821989637. Epub 2021 Feb 23.

Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer.

JAMA Otolaryngol Head Neck Surg. 2020 Dec 1;146(12):1109-1119. doi: 10.1001/jamaoto.2020.2107.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Treatment of Head and Neck Cancer-Sometimes, Less Is More.

作者信息

Galloway Thomas J, Ridge John A

机构信息

Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

出版信息

JAMA Otolaryngol Head Neck Surg. 2019 Dec 1;145(12):1167-1169. doi: 10.1001/jamaoto.2019.3078.

DOI:10.1001/jamaoto.2019.3078

PMID:31621802

Abstract

摘要

相似文献

Treatment of Head and Neck Cancer-Sometimes, Less Is More.

JAMA Otolaryngol Head Neck Surg. 2019 Dec 1;145(12):1167-1169. doi: 10.1001/jamaoto.2019.3078.

Aspiration pneumonia after concurrent chemoradiotherapy for head and neck cancer.

Cancer. 2015 Apr 15;121(8):1303-11. doi: 10.1002/cncr.29207. Epub 2014 Dec 23.

Survival of patients with head and neck cancer treated with definitive radiotherapy and concurrent cisplatin or concurrent cetuximab: A Surveillance, Epidemiology, and End Results-Medicare analysis.

Cancer. 2018 Dec 1;124(23):4486-4494. doi: 10.1002/cncr.31708. Epub 2018 Oct 17.

Improved overall survival and mortality in head and neck cancer with adjuvant concurrent chemoradiotherapy in national databases.

Head Neck. 2016 Feb;38(2):208-15. doi: 10.1002/hed.23869. Epub 2015 May 25.

Easing acceleration of head and neck chemoradiotherapy.

Lancet Oncol. 2012 Feb;13(2):113-5. doi: 10.1016/S1470-2045(11)70382-5. Epub 2012 Jan 18.

Concurrent chemoradiotherapy in older adults with squamous cell head & neck cancer: Evidence and management.

J Geriatr Oncol. 2016 May;7(3):145-53. doi: 10.1016/j.jgo.2016.01.010. Epub 2016 Feb 28.

Oral Oncol. 2018 Nov;86:132-140. doi: 10.1016/j.oraloncology.2018.09.023. Epub 2018 Sep 21.

Primary surgery for advanced-stage laryngeal cancer: A stage and subsite-specific survival analysis.

Head Neck. 2016 Sep;38(9):1380-6. doi: 10.1002/hed.24443. Epub 2016 Mar 25.

Survival After Definitive Chemoradiotherapy With Concurrent Cisplatin or Carboplatin for Head and Neck Cancer.

J Natl Compr Canc Netw. 2019 Sep 1;17(9):1065-1073. doi: 10.6004/jnccn.2019.7297.

Intra-arterial chemoradiotherapy for head and neck cancer.

Jpn J Clin Oncol. 2016 Jan;46(1):4-12. doi: 10.1093/jjco/hyv151. Epub 2015 Oct 20.

引用本文的文献

Microscopic Extranodal Extension in HPV-Negative Head and Neck Cancer and the Role of Adjuvant Chemoradiation.

Otolaryngol Head Neck Surg. 2021 Oct;165(4):536-549. doi: 10.1177/0194599821989637. Epub 2021 Feb 23.

Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer.

JAMA Otolaryngol Head Neck Surg. 2020 Dec 1;146(12):1109-1119. doi: 10.1001/jamaoto.2020.2107.